Cargando…
COVID-19: advance in laboratory diagnostic strategy and technology
ABSTRACT: SARS-CoV-2 is one of the beta-coronaviruses with the spike protein. It invades host cells by binding to angiotensin converting enzyme 2 (ACE2). This newly discovered virus can result in excessive inflammation and immune pathological damage, as shown by a decreased number of peripheral lymp...
Autores principales: | Yi, Kezhen, Rong, Yuan, Wang, Cheng, Huang, Lanxiang, Wang, Fubing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778859/ https://www.ncbi.nlm.nih.gov/pubmed/33389499 http://dx.doi.org/10.1007/s11010-020-04004-1 |
Ejemplares similares
-
Circular RNAs Are Promising Biomarkers in Liquid Biopsy for the Diagnosis of Non-small Cell Lung Cancer
por: Huang, Lanxiang, et al.
Publicado: (2021) -
Circulating tumor cells in hepatocellular carcinoma: single-cell based analysis, preclinical models, and clinical applications
por: Zhang, Qian, et al.
Publicado: (2020) -
SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies
por: Huang, Lanxiang, et al.
Publicado: (2021) -
Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer
por: Huang, Lanxiang, et al.
Publicado: (2022) -
Bringing the clinical laboratory into the strategy to advance diagnostic excellence
por: Lubin, Ira M., et al.
Publicado: (2021)